Ebert Lisa M, McColl Shaun R
Chemokine Biology Laboratory, Department of Molecular Biosciences, Adelaide University, Adelaide 5005, Australia.
J Immunol. 2002 Jan 1;168(1):65-72. doi: 10.4049/jimmunol.168.1.65.
Following infection, naive T cells are activated in the secondary lymphoid tissue, but then need to move to the infected tissue in the periphery to mediate their effector functions. The acquisition of inflammatory chemokine receptors, such as CCR5 and CCR6, may contribute to the efficient relocation of activated T cells to inflamed sites in the periphery. In keeping with this idea, the present study has demonstrated that CCR5 and CCR6 are up-regulated on CD4+ T cells upon activation in the MLR. The observed increase in expression correlated well with the acquisition of an activated/memory phenotype and was largely (CCR5) or completely (CCR6) separated temporally from the initiation of cell division. In contrast, the regulation of two other chemokine receptors, CXCR3 and CXCR4, occurred in close parallel with the cell division process. Increased mRNA levels are likely to contribute to the enhanced surface expression of CCR5 and CCR6, but in the case of CCR6, translocation of intracellular stores of protein to the cell surface may be an additional mechanism of regulation. The up-regulation of CCR5 was more extensive than that of CCR6, as only approximately half the activated CCR5+ T cells coexpressed CCR6. The increased expression of CCR5 resulted in enhanced chemotaxis toward the CCR5 ligand macrophage-inflammatory protein-1beta/CCL4, but up-regulation of CCR6 did not result in altered chemotactic responsiveness to macrophage-inflammatory protein-3alpha/CCL20, suggesting an alternative function for this receptor.
感染后,初始T细胞在二级淋巴组织中被激活,但随后需要迁移至外周的感染组织以发挥其效应功能。获得炎症趋化因子受体,如CCR5和CCR6,可能有助于激活的T细胞有效重新定位至外周的炎症部位。与此观点一致,本研究表明在混合淋巴细胞反应(MLR)中激活后,CD4+ T细胞上的CCR5和CCR6会上调。观察到的表达增加与激活/记忆表型的获得密切相关,并且在很大程度上(CCR5)或完全(CCR6)在时间上与细胞分裂的起始分开。相比之下,另外两种趋化因子受体CXCR3和CXCR4的调节与细胞分裂过程紧密平行发生。mRNA水平的增加可能有助于CCR5和CCR6表面表达的增强,但就CCR6而言,细胞内蛋白储存向细胞表面的转运可能是另一种调节机制。CCR5的上调比CCR6更广泛,因为只有大约一半激活的CCR5+ T细胞共表达CCR6。CCR5表达的增加导致对CCR5配体巨噬细胞炎性蛋白-1β/CCL4的趋化性增强,但CCR6的上调并未导致对巨噬细胞炎性蛋白-3α/CCL20的趋化反应性改变,提示该受体具有另一种功能。